Latest WHO Essential Medicines List: New Drugs And A New Way Of Tackling Antibiotic Resistance
Executive Summary
New drugs for leukemia, hepatitis C, HIV and tuberculosis have made it onto the 20th edition of the World Health Organization’s Essential Medicines List, which also features a new categorization system for antibiotics in a fresh effort to curb the rise of antibacterial resistance.
You may also be interested in...
Mylan Gears To Make Otsuka’s MDR TB Drug In India
Manufacturing plans for multidrug-resistant tuberculosis (MDR-TB) drug Deltyba (delamanid) in India appear to be gathering steam, with partners Otsuka and Mylan commencing the technology transfer process for the product, although activists are concerned about the broader contours of the arrangement. Deltyba is also expected to be used in children and adolescents in India.
Brazil’s New Essential Medicines List Says Hello to Alzheimer’s Patch And Goodbye To Older Hep C Drugs
Brazil has updated the list of essential medicines that are to be used in the public health system, the SUS.
AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)
The Pink Sheet spoke with CEOs of antibiotic firm Zavante and antifungal specialist Amplyx as well as a BARDA official during a roundtable discussion at the recent BIO convention about what's needed to boost antimicrobial drug development, including "push" and "pull" incentives for drug makers.